1. Long-Term Results of Autologous Stem Cell Transplantation for Primary Refractory or Relapsed Hodgkin’s Lymphoma 
Navneet S. Majhail, Daniel J. Weisdorf, Todd E. Defor, Jeffrey S. Miller, Philip B. McGlave, Arne Slungaard, Mukta Arora, Norma K.C. Ramsay, Paul J. Orchard, Margaret L. MacMillan, Linda J. Burns 
Biology of Blood and Marrow Transplantation 
Volume 12, Issue 10, Pages (October 2006)
DOI: /j.bbmt
Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
Probability of OS and PFS after ASCT for primary refractory or relapsed HL.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
Cumulative incidence of disease progression stratified by chemoresponsiveness after ASCT for primary refractory or relapsed Hodgkin’s lymphoma.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions

4. Figure 3
Probability of PFS (A) and OS (B) based on a prognostic model using low-risk (0 or 1 adverse prognostic factors), intermediate-risk (2 adverse prognostic factors), or high-risk (3 adverse prognostic factors) groups. The 3 adverse prognostic factors incorporated into the model included B-symptoms at pre-ASCT relapse, chemoresponsiveness pretransplantation relapse, and complete remission at the time of ASCT.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions